Wall Street Wizardry
  • Business
  • World News
  • Politics
  • Investing
  • Business
  • World News
  • Politics
  • Investing

Wall Street Wizardry

Investing

New RAD202 data confirms positive tumor uptake

by admin March 17, 2025
March 17, 2025
New RAD202 data confirms positive tumor uptake

Radiopharm Theranostics (RAD:AU) has announced New RAD202 data confirms positive tumor uptake

Download the PDF here.

This post appeared first on investingnews.com

previous post
Takeover Update – Offer Declared Best and Final
next post
New High Grade Gold Shoot at Ferke Project

Related Posts

Zodiac Gold Announces New $1M Financing, and Amends...

February 7, 2025

Dana Samuelson: Silver Facing Supply Shock, Will Price...

March 20, 2025

Adrian Day: Gold Price Drivers Stacking Up, Any...

July 15, 2025

Harvest Gold Meets 2025 Mosseau Exploration Expenditure Obligation...

February 3, 2026

Top 3 US Lithium Stocks of 2025

July 25, 2025

Lithium Market Update: Q3 2025 in Review

October 23, 2025

Oversubscribed Share Purchase Plan Raises $1.5 Million

November 27, 2025

Tech Weekly: Chip Stocks Soar on Taiwan Semiconductor...

January 17, 2026

Tech 5: NVIDIA Results Rattle Investors, Trump Signals...

August 31, 2025

Concentrate Offtake Agreements Signed for Nueva Sabana Copper-Gold...

May 27, 2025

    Join our mailing list to get access to special deals, promotions, and insider information. Your exclusive benefits await! Enjoy personalized recommendations, first dibs on sales, and members-only content that makes you feel like a true VIP. Sign up now and start saving!


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Editors’ Picks

    • 1

      Universal’s ‘Wicked: For Good’ creates a unique marketing challenge

      January 26, 2025
    • 2

      Financial Agreement signed releasing $2M grant

      January 23, 2025
    • 3

      Netflix shares soar as company reports surging revenue, tops 300 million subscribers

      January 23, 2025
    • 4

      Cyclopharm Signs US Agreement with HCA Healthcare for Technegas®

      January 23, 2025
    • 5

      Trump re-designates Iranian-backed Houthis as terrorists: ‘Threaten[s] security of American civilians’

      January 23, 2025
    • 6

      US security contractor will take charge of key checkpoint in Gaza as Israeli forces withdraw

      January 25, 2025
    • 7

      FDA officially authorizes Zyn nicotine pouches for sale following health review

      January 23, 2025
    • About us
    • Contacts
    • Privacy Policy
    • Terms and Conditions
    • Email Whitelisting

    Disclaimer: wallstreetwizardry.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2026 wallstreetwizardry.com | All Rights Reserved